Covid Update: India Reports 7,974 New Covid Cases, 14% Higher Than Yesterday

The cumulative vaccination coverage of India has exceeded 135.25 crores, the Union Health Ministry informed on Wednesday. 

New Delhi: India reported 7,974 new coronavirus cases on Wednesday. The number of active cases in the country declined to 87,245, according to the Union health ministry.

The number of active coronavirus cases in the country now accounts for 0.25 percent of the total caseload, the lowest since March 2020, while the national COVID-19 recovery rate was recorded at 98.38 percent, the highest since March 2020, said the ministry.  “Active cases constitute 0.25 percent of the country’s total positive cases, which is lowest since March 2020,” the ministry said.

With the administration of 68,89,025 COVID-19 vaccine doses in the last 24 hours, the cumulative vaccination coverage of India has exceeded 135.25 crore, the Union Health Ministry informed on Wednesday.

The ministry’s press release said, “India’s COVID-19 vaccination coverage has exceeded 134.61 Cr (1,34,61,14,483) as per provisional reports till 7 am today. This has been achieved through 1,41,10,887 sessions.”

Covid In Maharashtra

Thane has added 119 new cases of coronavirus, taking the infection tally in the Maharashtra district to 5,70,794 on Thursday. One more person also succumbed to the viral infection, which raised the death count in the district to 11,596.

Vaccines Can Become Variant-Proof, Says New Study Amid Omicron Alert

Researchers at the University of California, Los Angeles (UCLA) have found rare, naturally occurring T cells that are capable of targeting a protein found in SARS-CoV-2 and a range of other Corona viruses.

The findings suggested that a component of this protein, called viral polymerase, could potentially be added to COVID-19 vaccines to create a longer-lasting immune response and increase protection against new variants of the virus.

Most COVID-19 vaccines use a part of the spike protein found on the surface of the virus to prompt the immune system to produce antibodies. However, newer variants – such as Delta and Omicron – carry mutations to the spike protein, which can make them less recognizable to the immune cells and antibodies stimulated by vaccination.